GASTROESOPHAGEAL CANCER EPIDEMIOLOGY AND CLINICAL PRESENTATION. Prof Eric Van Cutsem, MD, PhD University Hospitals Leuven Belgium

Similar documents
Gastric and GE Junction Cancer: Epidemiology and Clinical Presentation

The international health care burden of cancers of the gastrointestinal tract and liver

/Webpages/zhang/chinese-full full- program.htm

Gastrointestinal pathology 2018 lecture 2. Dr Heyam Awad FRCPath

Gastro-oesophageal junction cancers (ICD10 C15.2, C15.5, C16.0) 1

Medicina Personalizada de Precisión en el Abordaje del Cáncer Gástrico. Dra Desamparados Roda Pérez Hospital Clínico de Valencia Incliva, CIBERONC

Disclosures. Gastric Intestinal Metaplasia and Early Gastric Cancer: Screening, Surveillance, and Endoscopic Therapy. ASGE Guidelines.

Oesophago gastric cancer the disease and the challenges. Muntzer Mughal

Epidemiology of gastric cancer

Hiatal Hernias and Barrett s esophagus. Dr Sajida Ahad Mercy General Surgery

Oncology in Emerging Markets

D espite its decreasing trend over many

June By: Reza Gholami

International Journal of Medical Science and Health Research

Implementing PAthways for Early Diagnosis (I-PACED)

Gastrointestinal pathology 2018 lecture 4. Dr Heyam Awad FRCPath

PDF # ESOPHAGEAL CANCER RISK CALCULATOR

GASTROINTESTINAL MALIGNANCIES

A Trip Through the GI Tract: Common GI Diseases and Complaints. Jennifer Curtis, MD

Analysing research on cancer prevention and survival. Diet, nutrition, physical activity and stomach cancer. Revised 2018

Surgery for Gastric and Oesophageal Cancer

Gastrointestinal Tract Cancer

Table 6.1 Summary information for colorectal cancer in Ireland,

Disclosures. GI Motility Disorders. Gastrointestinal Motility Disorders & Irritable Bowel Syndrome

Cancer in the North Africa

Helicobacter Pylori Testing HELICOBACTER PYLORI TESTING HS-131. Policy Number: HS-131. Original Effective Date: 9/17/2009

Cancer Survivors: - Asian Perspective

8/26/17. Smoking Cessation and Cancer Prevention Jussuf T. Kaifi, MD, PhD, FACS Chief, Section for Thoracic Surgery. Cancer in the United States

CANCER FACT SHEETS: STOMACH CANCER

PPIs: Good or Bad? 1. Basics of PPIs. Gastric Acid Basics. Outline. Gastric Acid Basics. Proton Pump Inhibitors (PPI)

Gastroenterology Tutorial

Functional Dyspepsia. Norbert Welkovics Heine van der Walt

CANCER FACT SHEETS: LIVER CANCER

CANCER FACT SHEETS: ALL CANCERS EXCLUDING NON-MELANOMA SKIN CANCER

Michael A. Choti, MD, FACS Department of Surgery Johns Hopkins Medicine, Baltimore, MD

Index. Note: Page numbers of article titles are in boldface type.

CANCER FACT SHEETS: BREAST CANCER

Epidemiology, aetiology and the patient pathway in oesophageal and pancreatic cancers

Clinico-Pathological Study of Endoscopic Gastric Biopsies

Surgical Problems in Proximal GI Cancer Management Cardia Tumours Question #1: What are cardia tumours?

Table 2.9. Case control studies of helicobacter pylori infection and oesophageal adenocarcinoma

Frequency of Barrett Esophagus in Patients with Symptoms of Gastroesophageal Reflux Disease

Cigarette Consumption in China ( ) Cigarette Consumption in Poland ( )

Mohammad A 1, Makaju R 2 1 Associate Professor, 2 Lecturer, Department of Pathology, Kathmandu University Medical School (KUMS), Banepa

Esophageal cancer: Biology, natural history, staging and therapeutic options

Peptic ulcer disease Disorders of the esophagus

Gastric cancer a clinicopathological study in a tertiary care centre of North-eastern India

GI CANCER SCREENING- Is It Worth It? Sylvia M. Oats, MSN, APRN, ANP-BC Susan H. Miedecke, MSN, APRN, FNP-BC Gastroenterology Clinic of Acadiana

CANCER = Malignant Tumor = Malignant Neoplasm

Gastric and Colon Cancer. Dr. Andres Wiernik 2017

Policy Evaluation: Proton Pump Inhibitors (PPIs)

MECHANISMS OF HUMAN DISEASE: LABORATORY SESSIONS GASTROINTESTINAL (GI) PATHOLOGY LAB #1. January 06, 2012

Variations in Breast Cancer Incidence and Mortality. M. Espié Centre des maladies du sein Hôpital St LOUIS APHP

SARCINA VENTICULARI IS A POSSIBLE CAUSATIVE MICROORGANISM OTHER THAN H.PYLORI IN GASTRIC OUTLET OBSTRUCTION PATHOGENESIS

Gastric Cancer Epidemiology and Prevention in the Low Resource Settings

Earlyoesophagealcancer. dr. Nina Zidar Institute of Pathology Faculty ofmedicine University of Ljubljana Slovenia

Cancers with Increasing Incidence Trends in the United States: Edgar P. Simard, PhD MPH

Quiz Adenocarcinoma of the distal stomach has been increasing in the last 20 years. a. True b. False

ESOPHAGEAL CANCER AND GERD. Prof Salman Guraya FRCS, Masters MedEd

GASTRIC CANCER. Joyce Au SUNY Downstate Grand Rounds July 11, 2013

Jun Lu, Chang-Ming Huang, Chao-Hui Zheng, Ping Li, Jian-Wei Xie, Jia-Bin Wang, and Jian-Xian Lin

Fatal Gastrointestinal Perforations in sudden death cases in Last 10 years at UMMC- Malaysia

Guidelines for the Management of Dyspepsia and GORD. Gastroenterology/ Acute Adult Governance. Drugs and Therapeutics Committee

سرطان المعدة. Gastric Cancer حمود حامد

The association of and -related gastroduodenal diseases

LIST OF ABBREVIATIONS

CLINICAL CHARACTERISTICS, ENDOSCOPIC IMAGE OF GASTROESOPHAGEAL REFLUX DISEASE IN THE ELDERLY

Influenza Update N 159

Epidemiology of chronic diseases in developing countries. Prof Isaac Quaye, UNAM SOM

1. Esophageal diverticulum located above the upper esophageal sphincter is called

Gastric Cancers At Kibogora Hospital

Gastrointestinal Disorders. Disorders of the Esophagus 3/7/2013. Congenital Abnormalities. Achalasia. Not an easy repair. Types

Cancers attributable to excess body weight in Canada in D Zakaria, A Shaw Public Health Agency of Canada

Gastroesophageal Reflux Disease, Paraesophageal Hernias &

Immunotherapy for Upper GI Cancers

Nutrition and Cancer. Prof. Suhad Bahijri

Functional Heartburn and Dyspepsia

The Association of CagA + Helicobacter pylori Infection and Gastric Carcinoma

Surveillance of Individuals At High Risk For Developing Pancreatic Cancer

Conventional Gastrectomy for Gastric Cancer. Franklin Wright UCHSC Department of Surgery Grand Rounds January 14, 2008

How to recognize them. H. Vahedi MD Gastroenterologist Associate Professor of Medicine DDRI

GI update. Common conditions and concerns my patients frequently asked about

Table 9.1 Summary information for stomach cancer in Ireland,

Upper Gastrointestinal Manifestations in Chronic Renal Failure Through Upper Gastrointestinal Endoscopy

Analysis of esophagogastric cancer patients enrolled in the National Cancer Institute Cancer Therapy Evaluation Program sponsored phase 1 trials

CLINICAL EFFECTIVENESS

Global Health Functional Food Market: Size, Trends & Forecasts ( ) December 2016

Cotton Trade 02/03 03/04 04/05 05/06 06/07 07/08 08/09 09/10 10/11 11/12 12/13

Trend of Cancer Incidence in Nepal from 2003 to 2012

Walking, even minimal, lowers death risk!

We need to know who is at risk of Hepatitis B and C infections so that we can identify them and offer them testing. Primary care has important roles

Association between Helicobacter Pylori Infection and Barrett s Esophagus in Patients with Gastro-Esophageal Reflux Symptoms and Erosive Esophagitis

CONVERSATION SCIENTIFIC PAPER

History. Prevalence at Endoscopy. Prevalence and Reflux Sx. Prevalence at Endoscopy. Barrett s Esophagus: Controversy and Management

Weight Loss Surgery. Outline 3/30/12. What Every GI Nurse Needs to Know. Define Morbid Obesity & its Medical Consequences. Treatments for Obesity

Disclosures. GI Cancers for the Boards. Esophageal Cancer. Esophageal Cancer: Risk Factors

CYCLOTRONS WORLD MARKET REPORT & DIRECTORY EDITION TOC and Summary USED IN NUCLEAR MEDICINE MARKET DATA, COMPANIES PROFILES.

Personalized Aspirin Therapy

Influenza Update N 157

Epidemiology of COPD Prof. David M. Mannino, M.D.

Transcription:

GASTROESOPHAGEAL CANCER EPIDEMIOLOGY AND CLINICAL PRESENTATION Prof Eric Van Cutsem, MD, PhD University Hospitals Leuven Belgium

Leuven city hall and University

Leuven: capital of beer AnheuserBusch-InBev Some important AB-Inbev brands are Stella Artois, Beck s, Jupiler, Budweiser, Leffe, Labatt, Hoegaerden, Bass and Corona.

Outline Incidence and Mortality in US Global Incidence and Mortality Incidence and Mortality in Europe Analytical Epidemiology: Etiology Courtesy A Cervantes for some slides

Gastric Cancer Epidemiology * Declining in incidence * 4th commonest cancer globally * 934,000 new cases per year * 2nd most common cause of death (700,000) globally * 2/3 of cases in Asia * 42% of cases in China * Early gastric cancer 5 year survival >90%

Ten leading cancer types for the estimated new cases in USA by sex in 2015. Siegel RL et al. Cancer Statistics, 2015. CA Cancer J Clin 2015; 65; 5-29

Ten leading cancer types for the estimated deaths in USA by sex in 2015. Siegel RL et al. Cancer Statistics, 2015. CA Cancer J Clin 2015; 65; 5-29

Trends in death rates for selected types of cancer in males in USA. Siegel RL et al. Cancer Statistics, 2015. CA Cancer J Clin 2015; 65; 5-29

Stage distribution of esophageal cancer from 2004-2010 In USA by race. All races White black Siegel RL et al. CA Cancer J Clin 2015; 65; 5-29

5 Year relative survival of esophageal cancer by race and stage at diagnosis from 2004-2010 In USA. All races White black Siegel RL et al. Cancer Statistics, 2015. CA Cancer J Clin 2015; 65; 5-29

Estimated Number of New Cancer Cases in 21 World Areas, 2012. *Region estimates do not sum to the worldwide estimate due to calculation method. Source: GLOBOCAN 2012. Torre LA et al. Global Cancer Statistics, 2012. CA Cancer J Clin 2015; 65; 87-108.

Estimated new cancer cases and deaths worldwide Torre LA et al. Global Cancer Statistics, 2012. CA Cancer J Clin 2015; 65; 87-108.

Estimated new cancer cases and deaths worldwide in developed countries Torre LA et al. Global Cancer Statistics, 2012. CA Cancer J Clin 2015; 65; 87-108.

Estimated new cancer cases and deaths worldwide in developing countries Torre LA et al. Global Cancer Statistics, 2012. CA Cancer J Clin 2015; 65; 87-108.

Gastric cancer incidence rate by sex and world area Torre LA et al. Global Cancer Statistics, 2012. CA Cancer J Clin 2015; 65; 87-108.

New cancer cases attributable to infection in 2008 Plummer M, et al. Int J Cancer 2015; 136:487-490

Esophageal cancer incidence rate by sex and world area Torre LA et al. Global Cancer Statistics, 2012. CA Cancer J Clin 2015; 65; 87-108.

Age-specific 5-year relative survival gastric cancer diagnosed in 2000-2007. The EUROCARE-5 De Angelis R et al. Lancet Oncol 2014; 15:23-34.

Age-standardized 5-year relative survival for gastric cancer followed up in 1999-2007. The EUROCARE-5 De Angelis R et al. Lancet Oncol 2014; 15:23-34.

European mean age-standardized 5-year relative survival for adult cancer patients diagnosed in 2000-2007. The EUROCARE-5 De Angelis R et al. Lancet Oncol 2014; 15:23-34.

Trends in incidence rate in men for esophageal cancer in Europe: rising incidence of adenocarcinoma. SCC ADENO Castro C et al. Ann Oncol 2014; 25; 283-290.

Risk factors Male > Female (2:1) Smoking Nutrition GERD - obesity H. pylori infection Atrofic gastritis Partial gastrectomy Genetic predisposition (e.g. HNPCC, FAP, hereditary diffuse gastric cancer, Peutz Jeghers) Waddel T et al. 2014

Gastro-esophageal cancer and Body Mass index Turati F et al. Ann Oncol 2013; 24; 609-617.

FACTS ON GASTRIC CANCER EPIDEMIOLOGY-1 Incidence of gastric cancer is decreasing in developed countries Incidence and mortality remains high in developing countries However it is still a severe global health issue Males:Females 2:1 Wide variation in incidence accross countries Highest incidence in East Asia (Korea, Japan, Mongolia and China), Central and Eastern Europe and South America Lowest incicence in North America, Nothern Europe and Africa

FACTS ON GASTRIC CANCER EPIDEMIOLOGY-2 Regional variations reflect differences in dietary patterns, food storage and availability of fresh products Prevalence of Helicobacter pylori infection Chronic infection of H. Pylori accounts for 90% of cases of non cardia gastric cancer Declining incidence may be due to: Increase availability of fresh fruits and vegetables Decreased reliance in salt preserved food Decreased incidence of H. pylori infection Decreased smoking in western countries Ford AC, et al. Br Med J 2014; 348; g3174.

FACTS ON GASTRIC CANCER EPIDEMIOLOGY-3 Increased Incidence and Mortality of upper third gastric cancer plus junctional and lower third adenocarcinoma of the esophagus In USA and Europe and in countries where the incidence of non cardia gastric cancer is low Predominant in males with high BMI and tobacco users

Etiology of Gastro-esophageal Junction Adenocarcinoma Esophageal Adenocarcinoma Gastric Adenocarcinoma H.pylori protective + H.pylori infection leading cause Obesity + Obesity ± Barrett s esophagus + Barrett s esophagus - Smoking + Smoking + Alcohol + Alcohol +

Siewert Classification for GE Junction Adenocarcinoma

Majority of gastric cancers present at late stage % 50 Stage of Gastric Cancer at Diagnosis 40 30 20 10 0 I II III IV 5-year Survival by Stage at Diagnosis 95% 77% 50% 5%

Clinical Presentation of Gastric Cancer Clinical presentation depends on stage of disease at diagnosis Early gastric cancer asymptomatic or incidental GI symptoms epigastric pain, bloating, indigestion Advanced gastric cancer Nausea / vomiting, hematemesis/malena, weight loss, gastric outlet obstruction, peritoneal effusion